Pituitary apoplexy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 22: | Line 22: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:22, 18 October 2017
|
Pituitary apoplexy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pituitary apoplexy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pituitary apoplexy epidemiology and demographics |
|
Pituitary apoplexy epidemiology and demographics in the news |
|
Risk calculators and risk factors for Pituitary apoplexy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]
Overview
The worldwide prevalence of pituitary apoplexy is 6.2 per 100,000 persons. The incidence of pituitary apoplexy is 0.7 per 100,000 persons.[1]
Epidemiology and Demographics
Prevalence
- Worldwide, the prevalence of pituitary apoplexy is 6.2 per 100,000 persons.[1]
Incidence
Age
- Pituitary apoplexy is commonly seen with a mean age of 57 years.
Gender
- Males are more commonly affected with pituitary apoplexy than females. Two-thirds of all patients are male.
References
- ↑ 1.0 1.1 Fernandez A, Karavitaki N, Wass JA (2010). "Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)". Clin Endocrinol (Oxf). 72 (3): 377–82. doi:10.1111/j.1365-2265.2009.03667.x. PMID 19650784.
- ↑ Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010). "Incidence of pituitary adenomas in Northern Finland in 1992-2007". J Clin Endocrinol Metab. 95 (9): 4268–75. doi:10.1210/jc.2010-0537. PMID 20534753.